AI News

Nvidia Invests $50M in Recursion for AI Drug Discovery

US-based chip manufacturer Nvidia will invest $50 million in biotech firm Recursion to expedite the development of artificial intelligence models for drug discovery.

As per Recursion’s announcement, the company has partnered with Nvidia to fast-track the creation of “innovative” foundational models in AI-assisted drug discovery.

Nvidia Invests $50M in Recursion for AI Drug Discovery

Nvidia’s $50 million investment will support Recursion’s use of AI-powered models to discover and design new treatments.

Recursion plans to utilize biological and chemical datasets exceeding 23,000 terabytes to operate artificial intelligence models on Nvidia’s cloud platform, as mentioned in the company’s statement.

Following the announcement of the investment, Recursion’s shares listed on the Nasdaq stock market saw an increase of over 115 percent.

You may also like this content

Follow us on TWITTER (X) and be instantly informed about the latest developments…


" is the world's first AI and Metaverse platform, where Metaverse is considered the internet of the future. We have compiled all the latest developments and information about AI and Metaverse in one platform for your convenience. In the future, we will produce AI and Metaverse land and coins. Keep following us for updates on this exciting development."

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button